Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Springer

Showing results (261-270 of 280) with videos related to

Pageof 28
Sort By:
Journal of Medicinal Chemistry|July 6, 2010
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitorsAlfonso Zambon, Delphine Ménard, Bart M J M Suijkerbuijk, et al.
Angiogenesis|July 31, 2012
Contrasting effects of sunitinib within in vivo models of metastasisJonathan C Welti, Thomas Powles, Shane Foo, et al.
Cancer Research|July 15, 1996
ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenograftsD C Blakey, P J Burke, D H Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agentA W Alberts, J Chen, G Kuron, et al.
Journal of Medicinal Chemistry|May 29, 2009
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ringDelphine Ménard, Ion Niculescu-Duvaz, Harmen P Dijkstra, et al.
Journal of the American Geriatrics Society|February 23, 2021
A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilitiesSidna Tulledge-Scheitel, Sarah J Bell, Jennifer J Larsen, et al.
Cancer Discovery|January 11, 2013
Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytesMalin Pedersen, Heidi V N Küsters-Vandevelde, Amaya Viros, et al.
Bioorganic & Medicinal Chemistry|July 30, 2010
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffoldsDan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Genome Announcements|January 21, 2017
Draft Genome Sequence of the Oleaginous Green Alga Tetradesmus obliquus UTEX 393B M Carreres, L de Jaeger, J Springer, et al.
Journal of Medicinal Chemistry|March 28, 2009
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF)Dan Niculescu-Duvaz, Catherine Gaulon, Harmen P Dijkstra, et al.
Pageof 28

Showing results (261-270 of 280) with videos related to

Sort By:
Pageof 28
Journal of Medicinal Chemistry|July 6, 2010
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitorsAlfonso Zambon, Delphine Ménard, Bart M J M Suijkerbuijk, et al.
Angiogenesis|July 31, 2012
Contrasting effects of sunitinib within in vivo models of metastasisJonathan C Welti, Thomas Powles, Shane Foo, et al.
Cancer Research|July 15, 1996
ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenograftsD C Blakey, P J Burke, D H Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agentA W Alberts, J Chen, G Kuron, et al.
Journal of Medicinal Chemistry|May 29, 2009
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ringDelphine Ménard, Ion Niculescu-Duvaz, Harmen P Dijkstra, et al.
Journal of the American Geriatrics Society|February 23, 2021
A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilitiesSidna Tulledge-Scheitel, Sarah J Bell, Jennifer J Larsen, et al.
Cancer Discovery|January 11, 2013
Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytesMalin Pedersen, Heidi V N Küsters-Vandevelde, Amaya Viros, et al.
Bioorganic & Medicinal Chemistry|July 30, 2010
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffoldsDan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Genome Announcements|January 21, 2017
Draft Genome Sequence of the Oleaginous Green Alga Tetradesmus obliquus UTEX 393B M Carreres, L de Jaeger, J Springer, et al.
Journal of Medicinal Chemistry|March 28, 2009
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF)Dan Niculescu-Duvaz, Catherine Gaulon, Harmen P Dijkstra, et al.
Pageof 28